Download Market Wire News App

HALO

Quote

Short

News

Articles

Message Board

Halozyme Therapeutics Inc. (NASDAQ : HALO ) News

News Releases

HALO News Releases

September 17, 2026 11:20:00 pm

PR Newswire

Halozyme Therapeutics, Inc. Announces Pricing of Upsized Private Offering of $1.3 Billion of Convertible Senior Notes due 2033

September 16, 2026 04:30:00 pm

PR Newswire

Halozyme Therapeutics, Inc. Announces Proposed Offering of $1.05 Billion of Convertible Senior Notes due 2033

June 30, 2026 04:02:00 pm

PR Newswire

Halozyme Appoints David Ramsay as President Drug Delivery

June 18, 2026 09:25:29 am

SeekingAlpha

As corporate profit margins remain elevated, these mid-caps stand out

June 15, 2026 06:00:00 am

PR Newswire

Halozyme Confirms It Projects Zero to Minimal Impact to Royalty Revenue Through At Least 2035 Based on Newly Released Draft Medicare Drug Price Negotiation Program Proposed Rule for IPAY 2029

June 13, 2026 08:54:14 am

SeekingAlpha

J&J multiple myeloma drug Talvey cuts mortality risk by up to 53% in late-stage trial

June 03, 2026 10:15:07 am

KlickAnalytics

Buy Recommendation Issued On HALO By Benchmark

June 03, 2026 10:15:07 am

KlickAnalytics

Buy Recommendation Issued On HALO By UBS

May 19, 2026 10:33:53 pm

SeekingAlpha

Halozyme Therapeutics: Royalty King

May 11, 2026 10:53:03 pm

SeekingAlpha

Halozyme outlines ENHANZE royalties exceeding $1B in 2026 while launching a new $1B buyback

	Next 10

Subscribe to Our Newsletter

Download The Market Wire News App

Schedule a 30 minute Brand Awareness meeting with Market Wire News

Link Market Wire News to Your X Account